Abstract
1 Six-point concentration-response curves were initially established for the contractile effect of angiotensin II (AII), at final concentrations of 10(-11) to 10(-6) M, on helically-cut strips of human chorionic plate arteries. The strips were then randomly allocated to one of four treatment groups: a control group and three treatment groups (n = 10 in each group) which were exposed to carrier or nitrendipine 10(-11), 10(-10) or 10(-9) M final concentration respectively, before the establishment of second concentration-response curves. 2 The initial responses of the tissues to AII were very similar in the four treatment groups with median EC50s ranging between 2.51 X 10(-10) and 4.04 X 10(-10) M (P greater than 0.8). The addition of nitrendipine was associated with significant (P less than 0.005) dose-related inhibition of AII-induced contractions. The median EC50 of the control group during the second half of the experiment was 1.77 X 10(-7) M, while that of the 10(-11) M nitrendipine treatment group was 2.16 X 10(-7) M. The EC50 for the other treatment groups could not be calculated from the curves due to the markedly blunted responses. 3 It is thus suggested that nitrendipine might be effective in vivo in the relief of vasospasm of the placental vascular system in pregnancy-induced hypertension.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aalkjaer C., Johannesen P., Pedersen E. B., Rasmussen A., Mulvany M. J. Morphology and angiotensin II responsiveness of isolated resistance vessels from patients with pre-eclampsia. Scand J Clin Lab Invest Suppl. 1984;169:57–60. doi: 10.3109/00365518409085378. [DOI] [PubMed] [Google Scholar]
- Broughton Pipkin F., Chinnery E. The effect of a calcium antagonist, nitrendipine, on the responses of isolated strips of human, chorionic plate artery to prostaglandins E2 and E1. Br J Pharmacol. 1985 Nov;86(3):705–709. doi: 10.1111/j.1476-5381.1985.tb08949.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broughton Pipkin F., Symonds E. M. Factors affecting angiotensin II concentrations in the human infant at birth. Clin Sci Mol Med. 1977 May;52(5):449–456. doi: 10.1042/cs0520449. [DOI] [PubMed] [Google Scholar]
- Dumez Y., Tchobroutsky C., Hornych H., Amiel-Tison C. Neonatal effects of maternal administration of acebutolol. Br Med J (Clin Res Ed) 1981 Oct 24;283(6299):1077–1079. doi: 10.1136/bmj.283.6299.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gant N. F., Daley G. L., Chand S., Whalley P. J., MacDonald P. C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973 Nov;52(11):2682–2689. doi: 10.1172/JCI107462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamberg M. Quantitative studies on prostaglandin synthesis in man. 3. Excretion of the major urinary metabolite of prostaglandins F 1 alpha and F 2 alpha during pregnancy. Life Sci. 1974 Jan 16;14(2):247–252. doi: 10.1016/0024-3205(74)90054-x. [DOI] [PubMed] [Google Scholar]
- Hillier K., Karim S. M. Effects of prostaglandins E1, E2, F1-alpha, F2-alpha on isolated human umbilical and placental blood vessels. J Obstet Gynaecol Br Commonw. 1968 Jun;75(6):667–673. doi: 10.1111/j.1471-0528.1968.tb00178.x. [DOI] [PubMed] [Google Scholar]
- Höffler D., Stoepel K. Nitrendipine in hypertension that is difficult to control. J Cardiovasc Pharmacol. 1984;6 (Suppl 7):S1060–S1062. [PubMed] [Google Scholar]
- Kitson G. E., Broughton Pipkin F. Effects and interactions of prostaglandins E1 and E2 on human chorionic plate arteries. Am J Obstet Gynecol. 1981 Jul 15;140(6):683–688. doi: 10.1016/0002-9378(81)90204-0. [DOI] [PubMed] [Google Scholar]
- Macpherson M., Broughton Pipkin F., Rutter N. The effect of maternal labetalol on the newborn infant. Br J Obstet Gynaecol. 1986 Jun;93(6):539–542. doi: 10.1111/j.1471-0528.1986.tb07950.x. [DOI] [PubMed] [Google Scholar]
- Maigaard S., Forman A., Brogaard-Hansen K. P., Andersson K. E. Inhibitory effects of nitrendipine on myometrial and vascular smooth muscle in human pregnant uterus and placenta. Acta Pharmacol Toxicol (Copenh) 1986 Jul;59(1):1–10. doi: 10.1111/j.1600-0773.1986.tb00127.x. [DOI] [PubMed] [Google Scholar]
- Skinner S. L., Cran E. J., Gibson R., Taylor R., Walters W. A., Catt K. J. Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma. Am J Obstet Gynecol. 1975 Mar 1;121(5):626–630. doi: 10.1016/0002-9378(75)90463-9. [DOI] [PubMed] [Google Scholar]
- Symonds E. M., Stanley M. A., Skinner S. L. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968 Mar 23;217(5134):1152–1153. doi: 10.1038/2171152a0. [DOI] [PubMed] [Google Scholar]
- Tulenko T. N. Regional sensitivity to vasoactive polypeptides in the human umbilicoplacental vasculature. Am J Obstet Gynecol. 1979 Nov 1;135(5):629–636. doi: 10.1016/s0002-9378(16)32988-x. [DOI] [PubMed] [Google Scholar]
- V Euler U. S. Action of adrenaline, acetylcholine and other substances on nerve-free vessels (human placenta). J Physiol. 1938 Jul 14;93(2):129–143. doi: 10.1113/jphysiol.1938.sp003631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warren A. Y., Craven D. J., Symonds E. M. Production of active and inactive renin by cultured explants from the human female genital tract. Br J Obstet Gynaecol. 1982 Aug;89(8):628–632. doi: 10.1111/j.1471-0528.1982.tb04717.x. [DOI] [PubMed] [Google Scholar]
